Altre lingue BCAL Diagnostics Limited

Azioni

BDX

AU0000160921

Mercato chiuso - Australian S.E. Altri mercati azionari 08:10:51 24/04/2024			Variaz. 5gg	Var. 1 gen.
0,095 ^AUD	0,00%		-9,52%	-4,04%

20/02	BCAL Diagnostics Limited riporta i risultati degli utili per il semestre conclusosi il 31 dicembre 2023	CI
2023	BCAL Diagnostics unisce le forze per condurre uno studio sul test del sangue per il cancro al seno in India	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BCAL Diagnostics Appoints CEO	06/03
BCAL Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	20/02
BCAL Diagnostics Joins Forces to Conduct Breast Cancer Blood Test Study in India	29/11
BCAL Diagnostics Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Fall 5%	14/11
BCAL Diagnostics Files for Additional Australian Patent Application	06/11
BCAL Diagnostics Appoints COO	05/09/23
Bcal Diagnostics Limited Appoints Shane Ryan as Chief Operating Officer Effective 21 September 2023	05/09/23
BCAL Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23
9,246,318 Ordinary Options of BCAL Diagnostics Limited are subject to a Lock-Up Agreement Ending on 21-JUL-2023.	21/07/23
54,752,379 Ordinary Shares of BCAL Diagnostics Limited are subject to a Lock-Up Agreement Ending on 21-JUL-2023.	21/07/23
BCAL Diagnostics Appoints Advisor	16/05/23
Bcal Diagnostics Limited Opens New Laboratory in Sydney	04/05/23
BCAL Diagnostics Opens Laboratory in Sydney	03/05/23
BCAL Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23/02/23
BCAL Diagnostics to Set Up Clinical Service Laboratory in Sydney	26/10/22
BCAL Diagnostics Limited Announces Establishment of Development & Clinical Service Laboratory	24/10/22
BCAL Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2022	30/08/22
BCAL Diagnostics Limited Enters US Product Development Agreement with Precion Inc	28/06/22
BCAL Files Foundational Patent Application	11/05/22
BCAL Files Foundational Patent Application	11/05/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BCAL Diagnostics Limited

Azioni

BDX

AU0000160921

Altre lingue

Filtri